Myopic Choroidal Neovascularization: Diagnosis and Treatment Update

AbstractPurpose of ReviewTo review the diagnosis and treatment of myopic choroidal neovascularization. Imaging tests currently available and the advantages of each modality for detecting choroidal neovascularization signs are discussed. The management options and the outcomes of different treatment options are also reviewed.Recent FindingsAnti-vascular endothelial growth factor has become the preferable choice of treatment in myopic choroidal neovascularization cases with improved results. The benefits of a single injection followed by PRN dosing were supported by randomized clinical trials.SummaryChoroidal neovascularization is a common vision threatening complication in patients with pathologic myopia. Most of the patients with this condition are younger than 50  years, and the major concern is to have vision preserved later in life. The investigation of myopic choroidal neovascularization imposes additional tests to be performed in most cases. Anti-vascular endothelial growth therapy has demonstrated superior efficacy over other treatment modalities. Howe ver, further studies are required for investigation of the risk factors for recurrences and the long-term treatment strategies.
Source: Current Ophthalmology Reports - Category: Opthalmology Source Type: research